share_log

Alterity Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcement ·  Jan 2 13:00
Summary by Futu AI
Alterity Therapeutics Limited, a development stage enterprise, has announced a security purchase plan (SPP Offer) to raise up to $2 million before costs. The SPP Offer includes the issue of up to 571,428,571 fully paid ordinary shares (SPP Shares) at $0.0035 per share, with one free-attaching option for each SPP Share issued, expiring on August 31, 2024 (Short Dated Options), and one free-attaching option for every three SPP Shares issued, expiring on August 31, 2026 (Long Dated Options). Eligible Shareholders may apply for a maximum of 8,571,429 SPP Shares ($30,000), with the offer opening on January 10, 2024, and closing on January 25, 2024. The SPP Offer is not underwritten and is available only to shareholders with registered addresses in Australia and New Zealand. The funds raised will support clinical trials, research efforts in neurodegenerative diseases, and general working capital. The SPP Shares and options are considered speculative investments.
Alterity Therapeutics Limited, a development stage enterprise, has announced a security purchase plan (SPP Offer) to raise up to $2 million before costs. The SPP Offer includes the issue of up to 571,428,571 fully paid ordinary shares (SPP Shares) at $0.0035 per share, with one free-attaching option for each SPP Share issued, expiring on August 31, 2024 (Short Dated Options), and one free-attaching option for every three SPP Shares issued, expiring on August 31, 2026 (Long Dated Options). Eligible Shareholders may apply for a maximum of 8,571,429 SPP Shares ($30,000), with the offer opening on January 10, 2024, and closing on January 25, 2024. The SPP Offer is not underwritten and is available only to shareholders with registered addresses in Australia and New Zealand. The funds raised will support clinical trials, research efforts in neurodegenerative diseases, and general working capital. The SPP Shares and options are considered speculative investments.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.